Medical Weight Loss
GLP-1 Weight Loss & Metabolic Medicine in Dallas, TX
Semaglutide and tirzepatide prescribed and managed by a provider who looks at thyroid, insulin, and metabolic markers, because weight is influenced by more than calories. Baseline labs are required before you start and repeated at 90 days if the scale has not moved. Brand-name Wegovy (semaglutide) and Zepbound (tirzepatide) available with self-pay pricing. This is medical weight management, not a quick-fix program.
repeated if you stall
APRN, FNP-C, ENP-C
your results call for it
licensed
How It Works
Medical Weight Management Built Around Your Biology
Weight loss is influenced by more than calories. Hormones, insulin resistance, thyroid function, stress physiology, and metabolic adaptation all play a role. Our programs address the full picture. The number on the scale is one part of it.
Wegovy (semaglutide) through NovoCare Pharmacy from $349 a month, and Zepbound (tirzepatide) through LillyDirect from $299 a month on self-pay, which is considerably less than retail pharmacy pricing. Insurance pathways are also available, and we submit prior authorizations on your behalf.
You pay the manufacturer's program directly for the medication. Our fee covers the clinical care around it: your evaluation, labs, titration, side effect management, and follow-up.
A compounded preparation is prescribed when there is a specific clinical reason for it, most commonly a dose or dosing schedule the commercial product cannot deliver, or a formulation that needs something added, such as B vitamins.
It is a clinical decision made for you at your visit, documented in your chart, and filled by a licensed 503A pharmacy against your individual prescription.
Important notice about compounded medications
Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as brand-name Wegovy (semaglutide), Ozempic, Mounjaro, or Zepbound (tirzepatide). They are prepared by a licensed 503A compounding pharmacy against an individual prescription and have not undergone FDA review for safety, efficacy, or manufacturing quality. Individual results vary. All prescribing is done after a thorough medical evaluation by your Navara provider, and eligibility is not guaranteed.
Fill out a medical intake before your appointment. We review your health history, prior weight loss experience, and current medications before your consult.
Meet with Jessica Boggs, APRN to review your goals, history, and the right medication pathway. Your lab order goes out the same day, or bring results from the last 90 days. Then a full Results Review where we build your plan.
If you qualify, your prescription goes to NovoCare or LillyDirect for brand-name, or to our partner 503A pharmacy if a compounded preparation is clinically indicated. Supplies are included either way.
Members get continued provider access for titration, side effect management, refills, and protocol adjustments. This is not set-and-forget prescribing.
Step 1, Get Started
Book Your Start Visit
- Full review of health history, goals, and prior weight loss experience
- $199 with labs from the last 90 days, $349 with the Weight Loss and Metabolic Panel ordered for you
- A 60 to 75 minute Results Review and your medication pathway, semaglutide or tirzepatide, brand or compounded
- Prescription sent if you qualify
- Then choose a monthly program with ongoing provider access, or pay per visit
Everything you need to start in one charge: your Start Visit, labs, your first month of medication, two in-office metabolic injections, and a follow-up visit built in. $899 with semaglutide, $1,299 with tirzepatide.
- Start Visit with your lab panel and Results Review, a $349 value
- First month of medication, tier 1
- Two in-office metabolic injections, B12 or Lipo-Mino
- Follow-up visit included
Medical Eligibility
Not Everyone Qualifies. That Is How It Should Be.
Semaglutide and tirzepatide are prescription medications. A thorough medical evaluation is required before any prescription is written. The following conditions may disqualify you or require additional review at your consultation.
GLP-1 medications are not indicated for individuals with a BMI below 27. A BMI of 27 or higher with at least one weight-related health condition is typically required for prescribing.
A personal history of a clinically diagnosed eating disorder is a contraindication that requires careful provider evaluation.
Compounded semaglutide and tirzepatide are not appropriate for patients with Type 1 diabetes or those using insulin. Patients with Type 2 diabetes require additional review.
Active gallbladder disease or a history of gallstones may affect eligibility. GLP-1 medications have been associated with gallbladder-related events and require provider evaluation.
Active substance use or a recent history of substance use disorder is reviewed on a case-by-case basis. This must be disclosed at your consultation.
Patients who have undergone bariatric surgery within the past 12 months require additional evaluation before GLP-1 medications can be considered.
A personal history of pancreatitis is a contraindication. GLP-1 receptor agonists have been associated with pancreatitis risk and cannot be prescribed to patients with this history.
A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Type 2 is an absolute contraindication for GLP-1 medications.
GLP-1 medications are not appropriate during pregnancy or breastfeeding. Patients actively planning to become pregnant in the near term are also not appropriate candidates.
Patients with a history of diabetic retinopathy require additional evaluation. Rapid glycemic changes associated with GLP-1 therapy may affect retinopathy status and must be reviewed.
This list is not exhaustive.
Your provider will review your full medical history, current medications, and any additional risk factors at your consultation before any prescription is written. Disclosing your complete health history is essential for your safety. If you are unsure whether a condition applies to you, bring it up at your appointment. We will not prescribe without a thorough evaluation.
Where BMI sits in this
BMI is one factor, not the whole picture. Your provider will also review your health history, current medications, and any weight-related conditions at your consultation. Some patients with a BMI slightly below 27 may still qualify depending on clinical context.
- BMI 30 or above, typically eligible
- BMI 27 to 29.9, eligible with at least one weight-related condition such as high blood pressure, pre-diabetes, or sleep apnea
- BMI under 27, generally not eligible
Maintenance Microdosing
You Lost the Weight. Now Keep It Off.
Once you reach your goal, the work changes. Stopping a GLP-1 cold is how the weight comes back. In the trials, people who stopped semaglutide regained about two thirds of what they had lost within a year, and people taken off tirzepatide regained a big share of theirs while the ones who stayed on kept losing. Microdosing is how we handle that. You stay on a lower maintenance dose than the one you used to lose the weight, set for you and adjusted only when you need it, and you skip the routine visits.
Semaglutide maintenance, medication only. Tirzepatide maintenance is $249 a month. Refills and messaging run through your patient portal. Anything extra is a la carte.
A lower dose to hold your ground
Below the dose you lost weight on. Enough to keep appetite and cravings steady so your results stay where you worked to put them.
Fewer side effects
Nausea, fullness and constipation track with dose. A lower dose usually means a quieter stomach and an easier routine to live with long term.
No routine visits
You do not need to see the provider unless you want to change your plan. A short portal message each month keeps you safe and keeps your refills moving.
A lower monthly cost
Less medication, no standing visit fee. Maintenance should cost less than the loss phase, and here it does.
Who it is for
- Established Navara patients with a completed intake on file
- Already at goal and stable on a maintenance dose, with no plan changes needed
- Not for starting treatment. New patients begin with a Start Visit
- Your provider decides when you are ready to move to maintenance
What $150 covers, and what it does not
- Included: your monthly medication, refill review, and messaging through the portal
- A la carte: labs are paid out of pocket when you need them
- Visits: any visit is booked and paid separately, including a dose or plan change
- Add-ons: B12, Lipo-Mino and other extras are priced on their own
How refills work, please read
When you take your 3rd injection of the month, send us a message in your patient portal. That message starts your refill. We review it, send your invoice, and send your prescription to the pharmacy once it is paid.
Your message needs four things: how you are doing, your current height, your current weight, and any side effects or new medications since your last refill. We use your height and weight to check your BMI every month, so a refill cannot go out without them.
We answer portal messages within 24 business hours. The portal is not for emergencies. For severe belly pain, vomiting you cannot stop, chest pain, trouble breathing or any emergency, call 911 or go to the nearest ER.
Program Pricing
Transparent Pricing. No Hidden Fees.
Medication pricing is per month and based on dosage tier. Your provider recommends the appropriate starting tier based on your health history and goals. Programs are available in clinic in Dallas and by virtual care in 9 states. Financing is available through Cherry.
Wegovy® (semaglutide) · paid to Novo Nordisk, not to Navara
Self-pay pricing through NovoCare Pharmacy. One month is one box of four pens, a 28-day supply, shipped free.
| Dose | Per month |
|---|---|
| 0.25mg and 0.5mg, first two fills | $199 |
| 0.25mg through 2.4mg, after that | $349 |
| Wegovy® HD (semaglutide) 7.2mg | $399 |
The $199 introductory price applies to patients new to the NovoCare program and runs through 31 December 2026. Patients with Medicare, Medicaid, TRICARE or VA coverage are excluded from these manufacturer savings programs. Prices verified 28 September 2026 and set by Novo Nordisk, who can change them at any time.
Zepbound® (tirzepatide) · paid to Eli Lilly, not to Navara
Self-pay pricing through LillyDirect, using single-dose vials rather than pre-filled pens, which is what keeps the price down.
| Dose | Per month |
|---|---|
| 2.5mg starter dose | $299 |
| 5mg | $399 |
| 7.5mg through 15mg | $449 |
The $449 price on 7.5mg and above requires refilling within 45 days of your previous delivery. Outside that window the price is $599 at 7.5mg, $699 at 10mg, $849 at 12.5mg and $1,049 at 15mg. Patients with Medicare, Medicaid, TRICARE or VA coverage are excluded from these manufacturer savings programs. Prices verified 28 September 2026 and set by Eli Lilly, who can change them at any time.
You pay the manufacturer directly for brand-name medication. Wegovy (semaglutide) self-pay through NovoCare currently starts around $349 a month and Zepbound (tirzepatide) through LillyDirect around $299, depending on your dose. That money goes to Novo Nordisk or Eli Lilly, not to us. Insurance may reduce it further. We do not mark up brand-name medication and we do not take a cut of it. Our fee above covers the clinical care around it, and nothing else. You are paying for evaluation, monitoring, dose decisions and refill authorization, not for a prescription. What we prescribe is always a clinical decision. Labs are not included in brand-name management and are priced separately.
Brand-name refill policy, please read
Wegovy (semaglutide) and Zepbound (tirzepatide) self-pay pricing through NovoCare and LillyDirect requires that refills be completed within 45 days of your previous supply to maintain the lowest available price tier.
To protect your pricing, submit your refill request at least 7 business days before day 38 of your current supply. Monthly management patients are contacted around day 28 to 31 of each supply, before that window opens, so in practice you should not have to track it yourself. That gives our team time to review and send your prescription electronically, and gives the pharmacy time to process and ship before your 45-day window closes.
Refill requests received after this window may result in a gap in supply or loss of self-pay pricing eligibility. Navara Health is not responsible for pricing changes or supply gaps resulting from late refill requests.
Supplement Support
Protect your progress on GLP-1 therapy.
Hydration and protein matter more when your appetite drops. Clean electrolytes, collagen protein, probiotics, and metabolic support, picked by Jessica and shipped by Fullscript.
Common Questions
What Patients Ask Most
How Care Works Here
Start with answers. Stay with a plan.
Every new patient begins the same way. One consultation, the right labs, and a full results visit where we walk through every number and build your plan together. Then you decide how your care continues.
01
Your Start Visit
Your symptoms, your history, your medications and what you have already tried. Your lab order goes out the same day.
02
Your Results Review
Sixty to seventy-five minutes. Every result explained in plain language, what it means for you, and exactly what happens next.
03
You Choose
Membership or pay per visit. Both are laid out below, so you know exactly what you are getting before you book.
Start Visit: $199 with labs from the last 90 days, or $349 with your labs ordered for you. Your Results Review is included either way.
Recommended
Membership
- Your Start Visit counts as your first month. Weight loss programs bill from your first medication order.
- Message your provider, answered the same or next business day
- Refills handled by message, no visit needed
- Dose changes and scheduled follow-ups included
- Six-month labs included in hormone and enclomiphene memberships
- Lab reviews included
For stable patients
Pay Per Visit
- Start Visit paid in full, separately
- No portal messaging with your provider
- Refills at a booked refill visit, $50
- Dose changes and follow-ups, $150 each
- Labs ordered and paid separately
- Lab reviews, $100 each
A forty-minute phone call is a medical visit. It deserves a chart, a real plan, and your provider's full attention, so clinical questions are answered at a scheduled visit or, for members, by message. And membership means you never wait for an appointment to ask.
Booking, pricing or billing questions? Text (469) 653-3124. Medical questions are answered at your visit.
Related
Keep Going
Written and clinically reviewed by Jessica Boggs, MSN, APRN, FNP-C, ENP-C, founder of Navara Health. Medical oversight by Simal Patel, MD.
Last reviewed October 23, 2026. This page is general information, not medical advice, and does not create a provider relationship.
Sources
- Endocrine Society clinical practice guidelines
- KDIGO
- Friás JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med 2021;385:503-515
- Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA 2024;331:38-48
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab 2022;24:1553-1564